ALLMedicine™ Hallucinogens Center
Research & Reviews 204 results
Journal of Analytical Toxicology; Farley M, Tran H et. al.
Jun 24th, 2021 - Driving under the influence of drugs (DUID) cases continue to challenge forensic toxicologists as both the volume and complexity of casework increases. Comprehensive DUID testing should also meet the drafted ASB/ANSI standard and the NSC-ADID reco...
Critical Care Clinics; Prisco L, Sarwal A et. al.
Jun 1st, 2021 - A trend in the increasing use of prescription psychoactive drugs (PADs), including antidepressants, antipsychotics, and mood stabilizers, has been reported in the United States and globally. In addition, there has been an increase in the productio...
Experimental and Clinical Psychopharmacology; Stevens AK, Gunn RL et. al.
May 11th, 2021 - Substance use in young adulthood and polysubstance users (PSU), in particular, pose unique risks for adverse consequences. Prior research on young adult PSU has identified multiple classes of users, but most work has focused on college students. W...
Drug and Alcohol Dependence; Manhapra A, Stefanovics E et. al.
Apr 18th, 2021 - Substance use disorder (SUD) is a major risk factor for homelessness, but the specific association of opioid use disorder (OUD) and homelessness in the context of their shared risk factors has not been the focus of prior studies. We used national ...
Journal of Clinical Psychopharmacology; Rocha JM, Rossi GN et. al.
Apr 13th, 2021 - The recognition of emotions in facial expressions (REFE) is a core aspect of social cognition. Previous studies with the serotonergic hallucinogens lysergic acid diethylamide and psilocybin showed that these drugs reduced the recognition of negati...
Clinicaltrials.gov 4 results
Oct 5th, 2018 - The primary objective of this double-blind, placebo-controlled pilot study is to assess the efficacy of psilocybin administration (4-phosphoryloxy-N,N-dimethyltryptamine), a serotonergic psychoactive agent, on psychosocial distress, with the speci...
Jul 19th, 2018 - This research is being done to study the psychological effects of psilocybin in cancer patients. Psilocybin is a naturally occurring substance found in some mushrooms that some cultures have used for centuries in religious practices. Psilocybin ha...
Jun 6th, 2018 - Background: Lysergic acid diethylamide (LSD) was extensively investigated in humans the 1950s and 1960s. Particularly, LSD attenuated anxiety in patients with cancer. Clinical research with LSD ended in the 1970s due to regulatory restrictions but...
Dec 7th, 2017 - Twenty volunteers between 21-50 years old will each participate in 16 total sessions, including sessions for: screening, preparation, experiment/drug, immediate follow-ups, a 1-month follow-up and 1 post completion urine collection. On each of fiv...
News 23 results
Aug 22nd, 2019 - Almost 1 million more Americans ages 12 or older reported using marijuana in their lifetime in 2018 than in 2017, according to new data from a national survey. The Substance Abuse and Mental Health Services Administration (SAMHSA) 2018 National Su...
Aug 13th, 2019 - Providers should screen all adult patients for illicit drug use when appropriate care is available, according to a U.S. Preventive Services Task Force (USPSTF) draft recommendation released on Tuesday. Available evidence provided the basis for a "...
MDedge Psychiatry; Jeff Craven
Jun 19th, 2019 - CRYSTAL CITY, VA. – Be aware of the potential iatrogenic properties of medications prescribed when patients present with new psychiatric symptoms, Henry A.
Hamid R. Tavakoli, MD, Andrew C. Buchholz, DO et. al.
May 4th, 2017 - Editor’s Note: This article has been adapted from an article originally published in Federal Practitioner (Tavakoli HR, et al. Kratom: a new product in an expanding substance abuse market.
Jan 1st, 2017 - Cannabis Last, but certainly not least, is marijuana, which is more widely used than all the other psychedelics combined, and is currently at the center of a national debate about its legalization. Although the director of the National Institute o.